Cleared Traditional

K972991 - MONITOR ONE NDX

K972991 is an FDA 510(k) clearance for MONITOR ONE NDX, manufactured by Qmed, Inc.. The device is a Class 2 Cardiovascular device with product code DPS cleared through the Traditional 510(k) pathway after a 478-day FDA review.

K972991 · Qmed, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1998
Decision
478d
Days
Class 2
Risk

K972991 is an FDA 510(k) clearance for the MONITOR ONE NDX. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Qmed, Inc. (Sag Harbor, US). The FDA issued a Cleared decision on December 3, 1998 after a review of 478 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Qmed, Inc. devices

FDA 510(k) Submission Details - K972991

510(k) Number K972991 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 12, 1997
Decision Date December 03, 1998
Days to Decision 478 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
353d slower than avg
Panel avg: 125d · This submission: 478d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPS Device Classification - Class 2, Special Controls

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPS Electrocardiograph

All 414
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K972991.
PRUCKA ENGINEERING INC. CARDIOLAB EP SYSTEM,VERSION 4.2
K993414 · Prucka Engineering, Inc. · Apr 2000
MARS UNITY WORKSTATION WITH HEART RATE VARIABILITY (HRV) OPTION
K991786 · General Electric Medical Systems Information Techn · Nov 1999
BMT ANSCORE HEALTH MANAGEMENT SYSTEM, MODEL 1.1
K991831 · Boston Medical Technologies, Inc. · Jun 1999
CAMBRIDGE HEART CH 2000 CARDIAC DIAGNOSTIC SYSTEM
K981697 · Cambridge Heart, Inc. · Oct 1998
MICROMEDICAL 12 LEAD SIMULTANEOUS CABLE
K974220 · Micromedical, Inc. · Aug 1998
CARDIOVISION SOFTWARE, MODEL S-CV5-96
K981807 · Shl Telemedicine International , Ltd. · Aug 1998